Navigation Links
AIDS Drug Found To Help Patients Undergoing Chemotherapy

Researchers say they discovered an anti-viral drug that helps reduce the risk of reactivating the hepatitis B virus in women who are being treated with chemotherapy for breast cancer.An estimated 12 percent // of breast cancer patients carry the hepatitis B virus and these patients are at risk of developing HBV reactivation during chemotherapy, which is a well-known complication resulting in varying degrees of liver damage that may lead to death.

Chemotherapy works by suppressing the immune system, which allows the HBV to replicate and spread through the blood stream. After chemotherapy is completed, the immune system recovers, and its attempt to clear HBV causes flare-ups of the virus.

Researchers say the anti-viral drug lamivudine can reduce the risk of HBV reactivation during and after chemotherapy. This drug was initially used for treating HIV in AIDS patients.

A recent study compared the incidence of HBV reactivation between chemotherapy patients receiving lamivudine and a control group. Only 7 percent of the chemotherapy patients taking lamivudine suffered HBV reactivation compared to 41 percent in the control group.Thus researchers say that these results show very clearly that prophylactic lamivudine significantly reduces the incidence of both HBV reactivation and hepatitis.

Thus , specialists say it would be better if breast cancer patients who are hepatitis B carriers should have anti-viral treatment before the start of chemotherapy.
'"/>




Page: 1

Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
(Date:8/29/2008)...ug. 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (N...ors declared a regular,quarterly cash dividend of ...008. The dividend will be paid on October 3, 2008,... About Landauer, Landauer is the leading provide... and environmental radiation exposure. For more th...
(Date:8/29/2008)...fic obligation reduced from $250 to $19 million, ...oston Scientific,Corporation (NYSE: BSX ) today a... Texas found two patents of Medtronic, Inc. (NYSE:...ng the prosecution of the patents,before the Unite... previously found that certain Boston Scientific b...
(Date:8/29/2008)... Dr. Milton Owens and the Coastal Center for O...ia to provide protection for cash paying patients ...ic community is benefiting. , .... Milton Owens and the Coastal Center for Obesity ...rovide protection for cash paying patients in the ...
(Date:8/29/2008)... Trusted life science software provider allows...ngage via GSA. , Reston, ...erging software engineering firm dedicated to the...ral Services Administration (GSA) Contract. The GS...h the ability to conveniently engage 5AM Solutions...
Breaking Medicine News(10 mins):Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2
...occus Aureus) is a bacteria resistant to certain a...ients who suffer //from weakened immune systems, e...own to spread because of poor hygiene. Countries l...ay, where MRSA has been relatively low and stable ...
...an children with AIDS, five Bulgarian Nurses and a...sion //in the Court of Appellations in Tripoli. ...pital aids made the outbreak possible since all th...ive results. But the Libyan authorities refused th...
...ng various opinions on the issue of doctors being ...atients //without fear of a ban. In its new draf... careful and remind them that the relationship wou...appropriate. In a move that nullifies the past p...
...rsity School of Medicine and colleagues finds it’s...lt medical procedures //about the dizzy feel of na...trongly affect how they respond to adversity – bot...d lead author Max E. Levine, Ph.D. ‘Being prepared...
Other Medicine News:Health News:Super-bug MRSA Getting Fitter And Out of Control 2Health News:Precautious Measure Help Tolerate Nausea In Patients 2Health News:Precautious Measure Help Tolerate Nausea In Patients 3
(Date:8/27/2008)...Spraying Set for Tonight in Parts of Bucks, Delawa..., Pa., Aug. 27 /PRNewswire-USNewswire/ -- After en...ial treatments, the Department of,Environmental Pr... protect,the public against the mosquito-borne Wes... administered between 8 p.m. and,midnight in porti...
(Date:8/27/2008)...rd Winning Research Team Makes Crucial Breakthroug...of Parkinson,s Disease, CHICAGO, Aug. 27 /PRNewsw...on today announced that scientists at The Universi...in the battle to slow or prevent the onset,of a ve...., The researchers have genetically produced the ...
(Date:8/27/2008)... - First Phase 3 data, from BLISS-52 trial, expec...l, BLISS-76, expected by fall 2009 -, ROCKVILLE, ...e,Sciences, Inc. (Nasdaq: HGSI ) today announced ...BLISS-76, the second of two pivotal Phase 3,random...) in patients with,active systemic lupus erythemat...
(Date:8/26/2008)... INDIANAPOLIS, Aug. 26 /- Semafore Ph... Seventh International Congress on Targeted,Therap...nal antiangiogenic,activity of vascular-targeted P...h VEGF and Bv8 signaling., PI3K is part of a very...has been shown to play a major role in cancer. Stu...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Surprise U S Supreme Court Decision Helps Michigan Citizens 13313 1mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 1mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 2mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 3mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 4mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 5mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 6RealSelf com Denies Lifestyle Lifts Trademark Claims and Files Countersuit 13307 1RealSelf com Denies Lifestyle Lifts Trademark Claims and Files Countersuit 13307 2Beauty com Partners With Fashion Designer Jenni Kayne 13304 1Beauty com Partners With Fashion Designer Jenni Kayne 13304 2Beauty com Partners With Fashion Designer Jenni Kayne 13304 3Beauty com Partners With Fashion Designer Jenni Kayne 13304 4
...led Findings Presented at 2007 APA Meeting Also Sh...axine Succinate, COLLEGEVILLE, Pa., May 21, 2007 /...e pooled analyses - one examining the,effect of de...,other on painful symptoms associated with major d...pooled analysis that examined the,effect of desven...
...t-hoc analysis shows nearly nine out of ten patien...at the end of 12 months, WASHINGTON, D.C., May 22,...III, open-label 12-14 month extension study (303),...gy (BSG) meeting,in Glasgow, Scotland in March 200...lerated in mild to moderate UC,patients. Today, se...
Other Medicine Technology:Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...ELISA products make us a leader in this field. Wit...into the busy laboratory, our Infectious Disease E...n-to-run consistency. Our Infectious Disease ELISA...e range of serological assays including ToRCH, EBV...
Medicine Products: